» Articles » PMID: 33046473

Prevalence and Determinants of Breast Cancer Screening in Four Sub-Saharan African Countries: a Population-based Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2020 Oct 13
PMID 33046473
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Breast cancer is the most prevalent cancer and the second leading cause of cancer-related deaths among women after cervical cancer in much of sub-Saharan Africa. This study aims to examine the prevalence and sociodemographic-socioeconomic factors associated with breast cancer screening among women of reproductive age in sub-Saharan Africa.

Design: A weighted population-based cross-sectional study using Demographic and Health Surveys (DHS) data. We used all available data on breast cancer screening from the DHS for four sub-Saharan African countries (Burkina Faso, Ivory Coast, Kenya and Namibia). Breast cancer screening was the outcome of interest for this study. Multivariable Poisson regression was used to identify independent factors associated with breast cancer screening.

Setting: Four countries participating in the DHS from 2010 to 2014 with data on breast cancer screening.

Participants: Women of reproductive age 15-49 years (N=39 646).

Results: The overall prevalence of breast cancer screening was only 12.9% during the study period, ranging from 5.2% in Ivory Coast to 23.1% in Namibia. Factors associated with breast cancer screening were secondary/higher education with adjusted prevalence ratio (adjusted PR)=2.33 (95% CI: 2.05 to 2.66) compared with no education; older participants, 35-49 years (adjusted PR=1.73, 95% CI : 1.56 to 1.91) compared with younger participants 15-24 years; health insurance coverage (adjusted PR=1.57, 95% CI: 1.47 to 1.68) compared with those with no health insurance and highest socioeconomic status (adjusted PR=1.33, 95% CI : 1.19 to 1.49) compared with lowest socioeconomic status.

Conclusion: Despite high breast cancer mortality rates in sub-Saharan Africa, the prevalence of breast cancer screening is substantially low and varies gradually across countries and in relation to factors such as education, age, health insurance coverage and household wealth index level. These results highlight the need for increased efforts to improve the uptake of breast cancer screening in sub-Saharan Africa.

Citing Articles

Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.

Ayebeng C, Okyere J, Okantey C, Addo I PLoS One. 2025; 20(1):e0316800.

PMID: 39804868 PMC: 11730425. DOI: 10.1371/journal.pone.0316800.


Clinical breast examination and its associated factors among reproductive age women in Ghana: multilevel logistic regression analysis.

Gebreegziabher Z, Semagn B, Walle A, Belay M, Wondie W, Degefaw G Front Oncol. 2025; 14():1413076.

PMID: 39777338 PMC: 11703916. DOI: 10.3389/fonc.2024.1413076.


Prevalence and determinants of pregnancy termination for childbearing women using the modified Poisson regression model: a cross-sectional study of the Tanzania Demographic and Health Survey (TDHS) 2022.

Mbona S, Chifurira R, Ndlovu B, Ananth A BMC Public Health. 2025; 25(1):56.

PMID: 39773354 PMC: 11706135. DOI: 10.1186/s12889-024-21203-3.


Determinants of breast cancer screening among women of reproductive age in sub-Saharan Africa: A multilevel analysis.

Seifu B, Mekuria Negussie Y, Asnake A, Daba Chinkey F, Fente B, Asmare Z PLoS One. 2024; 19(12):e0312831.

PMID: 39729464 PMC: 11676565. DOI: 10.1371/journal.pone.0312831.


Awareness and its determinant factors towards breast examination to detect breast cancer among reproductive age women in Kenya: Multi level analysis of the recent demographic and health survey data.

Wassie M, Zegeye A, Aemro A, Terefe B, Zeleke G, Workneh B PLoS One. 2024; 19(12):e0314700.

PMID: 39637069 PMC: 11620592. DOI: 10.1371/journal.pone.0314700.


References
1.
Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

2.
. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151(10):716-26, W-236. DOI: 10.7326/0003-4819-151-10-200911170-00008. View

3.
Black E, Richmond R . Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward. Global Health. 2019; 15(1):3. PMC: 6325810. DOI: 10.1186/s12992-018-0446-6. View

4.
Ssentongo P, Lewcun J, Candela X, Ssentongo A, Kwon E, Ba D . Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis. PLoS One. 2019; 14(11):e0225039. PMC: 6872165. DOI: 10.1371/journal.pone.0225039. View

5.
Titilayo A, Palamuleni M, Olaoye-Oyesola J, Owoeye O . Religious Perceptions and Attitudes of Men towards Discontinuation of Female Genital Cutting in Nigeria: Evidence from the 2013 Nigeria Demographic and Health Survey. Afr J Reprod Health. 2018; 22(1):20-28. DOI: 10.29063/ajrh2018/v22i1.2. View